Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

From Nuclear Medicine to Nuclear Medicine Theranostics

From Nuclear Medicine to Nuclear Medicine Theranostics Nucl Med Mol Imaging (2015) 49:83–84 DOI 10.1007/s13139-015-0342-4 ISSN (print) 1869-3474 EDITORIAL ISSN (online) 1869-3482 Dong Soo Lee Published online: 20 May 2015 Korean Society of Nuclear Medicine 2015 Editor-in-Chief was firmly introduced to the clinics by European colleagues. In the last issue, I announced a new editorial board that can This therapy was characterized as theranostics interestingly deal with every aspect of nuclear medicine, and especially the because the therapy response was evaluated with accompany- prospects of our discipline in the future. We do basic research ing nuclear imaging using SPECT (Lu-177) or PET (Y-90). not for the sake of science itself but for the purpose of meeting Theranostics promises the evaluation of the therapeutic effect clinical needs. During the last several decades nuclear and also the prediction of therapeutic efficacy. medicine has prospered, with the help and support of In addition to the use of small molecules to related sciences and engineering. These sciences were collec- biomacromolecules, particulate materials were recently pro- tively called ‘biology,’ and because of that, the global or posed to be used as platforms for radiolabelling and continental efforts were referred to as ‘Nuclear Medicine theranostics. This progress is mainly due to the http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Nuclear Medicine and Molecular Imaging Springer Journals

From Nuclear Medicine to Nuclear Medicine Theranostics

Lee, Dong
Nuclear Medicine and Molecular Imaging , Volume 49 (2) – May 20, 2015
Download PDF
2 pages

Loading next page...
 
/lp/springer-journals/from-nuclear-medicine-to-nuclear-medicine-theranostics-MjnTcKcalr

References (2)

Publisher
Springer Journals
Copyright
Copyright © 2015 by Korean Society of Nuclear Medicine
Subject
Medicine & Public Health; Nuclear Medicine; Imaging / Radiology; Orthopedics; Cardiology; Oncology
ISSN
1869-3474
eISSN
1869-3482
DOI
10.1007/s13139-015-0342-4
pmid
26082808
Publisher site
See Article on Publisher Site

Abstract

Nucl Med Mol Imaging (2015) 49:83–84 DOI 10.1007/s13139-015-0342-4 ISSN (print) 1869-3474 EDITORIAL ISSN (online) 1869-3482 Dong Soo Lee Published online: 20 May 2015 Korean Society of Nuclear Medicine 2015 Editor-in-Chief was firmly introduced to the clinics by European colleagues. In the last issue, I announced a new editorial board that can This therapy was characterized as theranostics interestingly deal with every aspect of nuclear medicine, and especially the because the therapy response was evaluated with accompany- prospects of our discipline in the future. We do basic research ing nuclear imaging using SPECT (Lu-177) or PET (Y-90). not for the sake of science itself but for the purpose of meeting Theranostics promises the evaluation of the therapeutic effect clinical needs. During the last several decades nuclear and also the prediction of therapeutic efficacy. medicine has prospered, with the help and support of In addition to the use of small molecules to related sciences and engineering. These sciences were collec- biomacromolecules, particulate materials were recently pro- tively called ‘biology,’ and because of that, the global or posed to be used as platforms for radiolabelling and continental efforts were referred to as ‘Nuclear Medicine theranostics. This progress is mainly due to the

Journal

Nuclear Medicine and Molecular Imaging – Springer Journals

Published: May 20, 2015

There are no references for this article.